OA11866A - Novel pharmaceutical. - Google Patents

Novel pharmaceutical. Download PDF

Info

Publication number
OA11866A
OA11866A OA1200100268A OA1200100268A OA11866A OA 11866 A OA11866 A OA 11866A OA 1200100268 A OA1200100268 A OA 1200100268A OA 1200100268 A OA1200100268 A OA 1200100268A OA 11866 A OA11866 A OA 11866A
Authority
OA
OAPI
Prior art keywords
hydrate
hydrate according
provides
methyl
thiazolidine
Prior art date
Application number
OA1200100268A
Other languages
English (en)
Inventor
Paul David James Blackler
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA11866A publication Critical patent/OA11866A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
OA1200100268A 1999-04-20 2000-04-19 Novel pharmaceutical. OA11866A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
OA11866A true OA11866A (en) 2006-03-02

Family

ID=10851901

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200100268A OA11866A (en) 1999-04-20 2000-04-19 Novel pharmaceutical.

Country Status (42)

Country Link
EP (2) EP1411055A1 (xx)
JP (2) JP4283449B2 (xx)
KR (1) KR100601244B1 (xx)
CN (2) CN101134756A (xx)
AP (1) AP1562A (xx)
AR (2) AR023562A1 (xx)
AT (1) ATE268770T1 (xx)
AU (2) AU4130900A (xx)
BG (1) BG65864B1 (xx)
BR (1) BR0009897A (xx)
CA (1) CA2382036A1 (xx)
CO (1) CO5170422A1 (xx)
CZ (1) CZ300653B6 (xx)
DE (1) DE60011419T2 (xx)
DK (1) DK1173436T3 (xx)
DZ (1) DZ3162A1 (xx)
EA (1) EA004232B1 (xx)
EG (1) EG24063A (xx)
ES (1) ES2218146T3 (xx)
GB (1) GB9909041D0 (xx)
HK (1) HK1045151B (xx)
HR (1) HRP20010770B1 (xx)
HU (1) HUP0200865A3 (xx)
IL (1) IL146078A0 (xx)
MA (1) MA26783A1 (xx)
MX (1) MXPA01010696A (xx)
MY (1) MY126034A (xx)
NO (1) NO320609B1 (xx)
NZ (1) NZ515166A (xx)
OA (1) OA11866A (xx)
PE (1) PE20010050A1 (xx)
PL (1) PL351135A1 (xx)
PT (1) PT1173436E (xx)
RS (1) RS50136B (xx)
SI (1) SI1173436T1 (xx)
SK (1) SK284991B6 (xx)
TR (1) TR200103040T2 (xx)
TW (1) TWI277616B (xx)
UA (1) UA71615C2 (xx)
UY (1) UY26112A1 (xx)
WO (1) WO2000063205A2 (xx)
ZA (1) ZA200108720B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
DE60217168T2 (de) * 2001-11-21 2007-10-04 Smithkline Beecham Plc, Brentford 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dion-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ2004844A3 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
SK284991B6 (sk) 2006-04-06
EP1411055A1 (en) 2004-04-21
YU81501A (sh) 2004-07-15
ATE268770T1 (de) 2004-06-15
JP2009143954A (ja) 2009-07-02
IL146078A0 (en) 2002-07-25
HUP0200865A2 (en) 2002-08-28
RS50136B (sr) 2009-03-25
HUP0200865A3 (en) 2005-04-28
KR100601244B1 (ko) 2006-07-19
ES2218146T3 (es) 2004-11-16
TR200103040T2 (tr) 2002-04-22
EG24063A (en) 2008-05-08
UA71615C2 (uk) 2004-12-15
CO5170422A1 (es) 2002-06-27
SI1173436T1 (en) 2004-12-31
DE60011419D1 (de) 2004-07-15
MXPA01010696A (es) 2002-06-04
KR20010110791A (ko) 2001-12-13
BR0009897A (pt) 2002-04-16
JP4283449B2 (ja) 2009-06-24
NO320609B1 (no) 2005-12-27
AU765911B2 (en) 2003-10-02
PL351135A1 (en) 2003-03-24
NZ515166A (en) 2004-02-27
AR023562A1 (es) 2002-09-04
NO20015104D0 (no) 2001-10-19
HRP20010770B1 (en) 2005-06-30
ZA200108720B (en) 2002-11-28
MA26783A1 (fr) 2004-12-20
HK1045151B (zh) 2005-03-18
DE60011419T2 (de) 2005-06-16
AP1562A (en) 2006-02-01
TWI277616B (en) 2007-04-01
DK1173436T3 (da) 2004-09-27
EP1173436B1 (en) 2004-06-09
HK1045151A1 (en) 2002-11-15
GB9909041D0 (en) 1999-06-16
CN101134756A (zh) 2008-03-05
WO2000063205A2 (en) 2000-10-26
WO2000063205A3 (en) 2001-01-25
EA200101101A1 (ru) 2002-04-25
PE20010050A1 (es) 2001-03-10
DZ3162A1 (fr) 2000-10-26
AU4130900A (en) 2000-11-02
JP2002542242A (ja) 2002-12-10
EA004232B1 (ru) 2004-02-26
BG106112A (bg) 2002-05-31
CZ300653B6 (cs) 2009-07-08
CA2382036A1 (en) 2000-10-26
AR023566A1 (es) 2002-09-04
CN1327447A (zh) 2001-12-19
MY126034A (en) 2006-09-29
AP2001002331A0 (en) 2000-04-19
AU2755202A (en) 2002-05-16
UY26112A1 (es) 2000-12-29
NO20015104L (no) 2001-12-19
HRP20010770A2 (en) 2002-10-31
BG65864B1 (bg) 2010-03-31
EP1173436A2 (en) 2002-01-23
PT1173436E (pt) 2004-10-29
SK14902001A3 (sk) 2002-02-05
CZ20013759A3 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
EP1173435B1 (en) Polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US6815457B1 (en) Thiazolidinedione derivative and its use as antidiabetic
EP1277753A1 (en) Thiazolidinedione derivative and its use as antidiabetic
OA11866A (en) Novel pharmaceutical.
US7358366B2 (en) Thiazolidinedione derivative and its use as antidiabetic
EP1173437B1 (en) Thiazolidinedione derivative and its use as antidiabetic
AU2754902A (en) Novel pharmaceutical